Exploring the Relationship Between Anastasis and Mitochondrial ROS-Mediated Ferroptosis in Metastatic Chemoresistant Cancers: A Call for Investigation

This review explores the complex relationship between anastasis, ferroptosis, and chemoresistance in metastatic chemoresistant cancers, emphasizing the role of mitochondrial changes and reactive oxygen species (ROS) in ferroptosis. It highlights the potential of targeting molecular pathways involved in anastasis to enhance the efficacy of ferroptosis inducers, offering a synergistic approach to overcoming chemoresistance. The study suggests that understanding the interactions between DNA damage response proteins, metabolic changes, and redox states during anastasis and ferroptosis could lead to new combinatorial therapeutic regimens. Additionally, the review discusses the significance of lipid metabolism, particularly GPX4 and System Xc-, in ferroptosis and cancer progression. Integrating these insights into strategies targeting chemoresistance and exploring synergy with immunotherapy could advance treatments for chemoresistant cancers, potentially revolutionizing personalized cancer therapy and drug development.